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Summary
Background: Schistosomes are parasitic blood flukes that inhabit the portal blood system of
humans. Ingested red cells are lysed in the gastrodermis to enable the parasites to digest
hemoglobin. Saposin-like proteins (SAPLIPs) have been reported from the gastrodermis of related
flukes, and at least one is hemolytic and a promising vaccine antigen. We now provide the first
report of SAPLIPs from schistosomes and explore their role in host—parasite interactions.
Methods: We identified expressed sequence tags encoding a family of SAPLIPs from Schistosoma
mansoni and produced one (termed Sm-SLP-1) in recombinant form using baculovirus. The
anatomic site of SLP-1 expression within the worm was assessed and its recognition by sera
from chronically infected humans and mice was determined. The vaccine efficacy of Sm-SLP-1
was tested in a mouse model.
Results: Full-length sequences were obtained for two cDNAs, Sm-slp-1 and Sm-slp-2. The Sm-slp-
1 open reading frame contained a single SAPLIP domain while Sm-slp-2 had a double domain. Sm-
SLP-1 was immunolocalized to the gastrodermis of adult worms, but did not confer protection in a
murine vaccination model of schistosomiasis. Mice infected with S. mansoni generated a specific
antibody response to Sm-SLP-1. Individuals who were infected with S. mansoni had IgG that
recognized Sm-SLP-1. IgG levels were statistically higher in individuals with heavy infection.
Conclusions: Sm-SLP-1 is expressed in the gastrodermis of S. mansoni. It is immunogenic in
humans and mice, but is not protective as a vaccine in its current form. Schistosome SAPLIPs
warrant further attention to elucidate their roles in host—parasite interactions and to further
explore their potential as vaccine and diagnostic antigens.
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Human schistosomes infect more than 200 million people
worldwide with at least 600 million more at risk of infection,1
making them a leading cause of parasite-induced morbidity.
The World Health Organization (WHO) estimate of 0.5% dis-
ability weight assigned to schistosomiasis was recently
revised by King et al. to 2—15%.2 There are three major
species of human medical significance, Schistosoma haema-
tobium, Schistosoma japonicum, and Schistosoma mansoni.
Schistosomes are exclusive blood feeders, and it is
estimated that female S. mansoni parasites can ingest
approximately 330 000 erythrocytes per hour.3 The hemoglo-
bin (Hb) degradation pathway in schistosomes has been
partially elucidated,4,5 however the step immediately pre-
ceding this, hemolysis, has received far less attention. Ery-
throcytes ingested by schistosomes are thought to be lysed by
the action of a hemolysin(s) within the esophagus and intes-
tine,6,7 which is proposed to form pores in the erythrocyte
membrane.8 Hemolysins may play additional roles in the
parasite — egg extracts of S. japonicum contain lytic mole-
cules that are thought to aid their movement through the
tissues and into the gut lumen for excretion.9 Despite these
earlier studies, molecule(s) involved in hemolysis and general
pore formation have yet to be characterized in any detail
from schistosomes.
Recently, lytic proteins were identified from two liver
fluke species: clonorin from Clonorchis sinensis10 and FhSAP1
and FhSAP2 from Fasciola hepatica.11 The proteins share
sequence homology to amoebapores, pore-forming peptides
from Entamoeba histolytica,12 and belong to the saposin-like
protein (SAPLIP) family of distantly related polypeptides that
have six conserved cysteine residues forming three disulfide
bridges.13—16 SAPLIPs are found in all animals ranging from
protozoa to mammals, and where known, their function
seems to involve interactions with lipids. Clonorin, from C.
sinensis, is expressed exclusively in the gut of adult flukes10
and was proposed to lyse ingested host cells for nutritional
purposes. FhSAP2 of F. hepatica is found in the excretory/
secretory (ES) products, which act externally of the para-
site,11 and although it has not been localized to a defined
tissue within the parasite, this protein might also be involved
in feeding. Recombinant FhSAP2 is partially protective in
vaccine trials using rabbits,11 indicating that helminth pore-
forming proteins might be potential vaccine candidates.
Here we describe the identification and characterization
of two cDNAs encoding SAPLIPs from S. mansoni, Sm-slp-1 and
Sm-slp-2. The SLP-1 protein is expressed in the gastrodermis
of the parasite and is recognized by antibodies from infected
mice and human subjects, but does not appear to be an
efficacious vaccine antigen in amurinemodel of S. mansoni in
its current form.
Materials and methods
Sequence identification, cDNA library PCR, and
sequence analysis
Clonorin, the saposin-like protein from the liver fluke C.
sinensis, was used to search GenBank (nr) and dbEST data-
sets by BLAST search (http://www.ncbi.nlm.nih.gov/BLAST/).17 An S. japonicum expressed sequence tag (EST)
was identified and subsequently used to identify homologous
sequences from S. mansoni. cDNA and predicted protein
sequences were analyzed using MacVector version 7.2.,
and predicted signal peptides were assessed using SignalP
(http://www.cbs.dtu.dk/services/SignalP/).18 Where ESTs
did not encode full-length cDNA sequences (Sm-slp-2), the 50
and 30 termini were obtained by PCR using a combination of
gene-specific oligonucleotide primers designed from the EST
sequences and vector-derived primers that flanked the clon-
ing site of an S. mansoni adult worm cDNA library con-
structed in lZAP-CMV (Stratagene). Primers used were as
follows: Sm2F (50 TCGTCCACTCGAAACTCCGGA) to find the 30
end and Sm2GCR (50 CTCCGGAGTTTCGAGTGGACG) to find
the 50 end. Multiple sequence alignments were assembled
with ClustalW using the amino acid sequences between the
first and sixth cysteine residues of each individual SAPLIP
domain.
Expression and purification of recombinant
proteins in baculovirus
Recombinant proteins were expressed in a baculovirus shuttle
plasmid (pMelBac, Invitrogen) fused to an N-terminal melittin
signal peptide. Primers incorporating a six-residue GC-rich
clamp followed by restriction sites for Sac I (50) and Nco I
(30) were designed to span the entire open reading frames
(ORFs) of Sm-SLP-1 and Sm-SLP-2 without their predicted
signal peptides. 30 Primers contained sequence encoding a
6His tag and stop codon for downstream purification using
metal ion affinity chromatography. The following primer
sequences were used for SLP-1: Sm1pmbF (50 GCGCGCG-
AGCTCTACTCTGTCAAGAATGTGGAT); Sm1pmbR (50 GCGCGC-
CCATGGTTAATGGTGATGGTGATGATGACATAAAGGAGTCAATTT-
GCA); and for SLP-2: Sm2pmbF (50 GCGCGCGAGCTCAACAAAAT-
TAATTTACTTACTAAG); Sm2pmbR (50 GCGCGCCCATGGTTAATG-
GTGATGGTGATGATGGTAGAGGATAAGTTTGAAAAG). Expres-
sion and purification of recombinant proteins in both pMelBac
and in a modified pMelBac plasmid, termed pHotWax, were as
previously published.19 Removal of C-terminal purification
tags (V5 and His epitopes) from recombinant proteins
expressed in pHotWax was performed using AcTEV Protease
(Invitrogen) according to the manufacturer’s instructions. To
assess theabilityof recombinantproteins todimerize,Western
blots of both native (samples were not boiled or reduced) and
reduced/denatured Sm-SLP-1, as well as adult schistosome
extracts (SmTX)20 were probed with Sm-SLP-1-specific anti-
serum. Hemolysis assays using recombinant SLPs were con-
ducted as described previously.21
Antibody production and immunolocalization
Antisera against recombinant Sm-SLP-1 (expressed in pMel-
Bac) formulated with Freund’s complete (first immunization)
and incomplete (second and third immunizations) adjuvants
were raised in female CBA/CaH mice as previously
described.22 Immunolocalization using fluorescence micro-
scopy was performed on paraformaldehyde-fixed adult worm
sections of S. mansoni as published elsewhere.22 All animal
research was approved by the Animal Ethics Committee of
the Queensland Institute of Medical Research.
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A group of 10 female CBA/CaH mice were vaccinated with
25 mg Sm-SLP-1 emulsified in Freund’s complete adjuvant as
described above. A group of control mice were immunized
with phosphate-buffered saline (PBS)/adjuvant. The rest of
the vaccine trial including immunization regimen, parasite
challenge, necropsy of mice, and assessment of parasite
burdens (adult worms and eggs in liver) were performed as
described elsewhere by us.22
Detection of mouse and human anti-SLP-1
antibody responses
Indirect ELISA was used to determine whether recombinant
Sm-SLP-1 was recognized by serum antibodies from vacci-
nated and control mice before and after parasite challenge,
and humans living in the schistosomiasis endemic areas of
Minas Gerais state, Brazil. Microtiter plates were coated
overnight at 4 8C with 0.5 mg recombinant Sm-SLP-1 per well
or 0.5 mg of S. mansoni adult worm extract solubilized in 1%
Triton X-100 in PBS (SmTX). Both proteins were diluted to
5 mg/ml in coating buffer (0.06 M NaCO3, pH 9.6) and applied
to microtiter plates (100 ml/well). For human studies, assem-
bly of cohorts and ELISA methods were as previously
described using the Sm-TSP-2 recombinant protein22 except
that human sera were diluted 1:5000.
The ethical review board of GeorgeWashington University,
the ethical committee of Centro de Pesquisas Rene Rachou
(FIOCRUZ), and the Federal Brazilian Ethical Review Board
(CONEP) reviewed and approved the study of chronically
infected individuals (egg-positive and egg-negative) from
endemic areas in Minas Gerais state, Brazil. The ethical
review board of the Centro de Pesquisas Rene Rachou (FIO-
CRUZ) reviewed and approved the study of non-endemic egg-
negative controls and putatively resistant individuals.
A one-wayanalysis of variance (ANOVA)procedurewas used
with IgG levels to Sm-SLP-1 as the quantitative dependent
variable and with the following categories: (1) non-endemic
negative control, (2) putative resistant, (3) egg-negativeFigure 1 Multiple sequence alignment of translated Schistosoma e
protein (SAPLIP) family. AF521090 corresponds to Sm-SLP-1 and AI97
obtained. GenBank accession numbers are listed following schistosom
(exceptions are Sm01689which is GeneDB ID and C605193.1 which is a
respectively. The conserved cysteine residues are boxed in gray and th
Conserved tyrosines found in saposins are shaded in blue. Gaps hav(resident in endemic area), (4) light infection (1—99 eggs
per gram (epg)), (5) moderate infection (100—399 epg ),
and (6) heavy infection (399 epg). Analysis of variance was
used to test the hypothesis that themeans among these groups
were equal. Once a difference had been determined to exist
among the means between groups, a Bonferroni post-hoc test
(for pairwise multiple comparisons) was used to determine
whichmeans differ between pairs of groups, yielding amatrix,
which indicated significantlydifferent groupmeansat analpha
level of 0.05.
For ELISAs with mouse sera, wells were washed three
times in phosphate-buffered saline plus 0.05% Tween 20
(PBST) , blocked for 1 hour at 37 8C with 2% bovine serum
albumin (BSA) /PBST and washed again three times in PBST.
Sera were titrated using doubling dilutions from 1:100 to
1:204 800. Plates were incubated for 1 hour at 37 8C, washed
three times in PBST then reacted with anti-mouse Ig-horse-
radish peroxidase (HRP) diluted 1:5000 in PBST for 1 hour at
37 8C. After three final washes in PBST, wells were incubated
with 2,20-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)
(ABTS) (Chemicon) substrate for 30 min. Absorbance was
measured colorimetrically in an automated plate reader
(BioRad) at 405 nm.
Results
cDNAs encoding schistosome SAPLIPs
Using the predicted protein sequence of clonorin from C.
sinensis as the query, a tBLASTn search of the Schistosoma
ESTs was undertaken. One of the homologues identified from
S. japonicum (EST BU712004) encoded a full-length predicted
protein with a signal peptide and a single SAPLIP domain. The
predicted ORF of BU712004 was then used to perform a
BLASTp search of the S. mansoni translated amino acid
contigs at http://bioinfo.iq.usp.br/schisto6/. Eight distinct
contigs with greater than 18% identity over at least 50 amino
acids were identified (Figure 1). Two of these contigs were
selected for further analysis: (1) ESTAF521090 corresponded
to clone p33F5, a cDNA expressed in adult and larval stagesxpressed sequence tags (ESTs), which belong to the saposin-like
7047 corresponds to Sm-SLP-2 before full-length sequence was
e species: Sm, Schistosoma mansoni; Sj, Schistosoma japonicum
contig ID). D1 and D2 refer to SAPLIP domains 1 and 2 of AI977047,
e histidine thought to be involved in dimerization is shaded pink.
e been introduced to maximize amino acid alignments.
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trapping technique;23 however, due to the low identities
between SAPLIP family members, p33F5 was initially classed
as having no homologues of known function. (2) ESTAI977047
contained part of an N-terminal signal peptide (missing the
initiator methionine) that obtained a positive score on sig-
nalP (http://www.cbs.dtu.dk/services/SignalP/) followed
by one full length SAPLIP domain and a partial second SAPLIP
domain (containing the first four cysteines).
Using PCR with gene-specific primers and cDNA library as
template, the 50 and 30 ends of Sm-SLP-2 were identified, and
confirmed that this mRNA encoded a protein with two SAPLIP
domains (Figure 2A). Sm-SLP-1 ORF comprised 114 amino
acids (including a signal peptide of 18 residues) with aFigure 2 Comparison of Schistosoma mansoni SLP-1 and SLP-2 pre
family of proteins. (A) Schematic representation of the general arch
include signal peptides (SP), the six-cysteine containing domain,
alignment of Sm-SLP-1 and SLP-2 with other SAPLIPs using the SAPLIP
Schistosoma japonicum (GenBank accession number BU712004); E
histolytica amoebapore B (CAA54226); Ac-PFP-1 (Ac-SLP-1), Ancy
Caenorhabditis elegans SAPLIP protein family 4 (AAA81416)
(BAA32237); Sap_B_human, Homo sapiens saposin B (NP_00103593
H. sapiens pulmonary surfactant B (P07988); clonorin, Clonorchis
(AF286903); NK_Lysin, Sus scrofa NK-lysin (CAA59720); Aoah_hum
discoideum AX4 countin (XP_643887); Ce_ZK455.4, C. elegans hy
sphingomyelin phosphodiesterase 1 (BAD93012). The six conserve
bonding patterns shown underneath (1—6, 2—5, 3—4). Hydrophobic
saposins or alanine in SAPLIPs and green highlights the conserved tyro
involved in dimerization of amoebapores is shaded in pink. Predicted
alignment, and putative N-linked glycosylation sites are shown in bopredicted molecular mass of 11 524.31 Da and pI of 7.00.
Sm-SLP-2 had an ORF of 213 amino acids (including a signal
peptide of 21 residues and two SAPLIP domains) with a
predicted molecular mass of 21 794.18 Da and pI of 6.08.
The single SAPLIP domain from Sm-SLP-1 and both SAPLIP
domains from Sm-SLP-2 possessed the general primary
sequence features of the SAPLIP family of lipid-interacting
proteins,16 including the positioning of the six cysteine resi-
dues involved in disulfide bond formation and the general
number and positioning of hydrophobic residues (Figure 2B).
The conserved tyrosine found in saposins between helices 3
and 4 is present in Sm-SLP-1 and both SAPLIP domains of SLP-
2. Neither Sm-SLP-1 nor SLP-2 contained the His at the end of
helix 5 that is responsible for dimerization of amoebapores.24dicted proteins with other members of the saposin-like (SAPLIP)
itecture of members of the SAPLIP family. Features highlighted
and predicted N-glycosylation sites (N). (B) Multiple sequence
domain between the first and sixth cysteines only. Sj_BU712004,
hA, Entamoeba histolytica amoebapore A (M83945); EhB, E.
lostoma caninum saposin-like protein (DQ855414); Ce_spp4,
; Sap_A_slimemould, Dictyostelium discoideum saposin A
0); Sap_C_bovine, Bos taurus saposin C (P26779); SPB_human,
sinensis clonorin (AF421960); FhSAP2, Fasciola hepatica SAP2
an, H. sapiens acyloxyacyl hydrolase (BAD97196); countin, D.
pothetical protein (CAA91493); Asm_human, H. sapiens acid
d cysteine residues are boxed in gray with predicted disulfide
residues are boxed in blue; yellow denotes conserved proline in
sine (or phenylalanine) in saposins. The histidine predicted to be
alpha-helices of amoebapore A are shown as solid lines above the
ld font. Gaps have been introduced to maximize the alignment.
Saposin-like proteins in Schistosoma mansoni e43Only one of the SAPLIP-like ORFs encoded by the S. mansoni
ESTs contained a histidine in this position (Figure 1).
Expression of recombinant SAPLIPs in insect cells
Recombinant Sm-SLP-1 was secreted by Sf-9 and Hi5 cells
that were infected with recombinant baculovirus carrying
Sm-SLP-1 cDNA in either pMelBac (rSLP-1) or pHotWax (rSLP-
1—pHW). Recombinant proteins were purified via the 6His
tag under native conditions using Ni-NTA (nickel-nitrilotria-
cetic acid) affinity chromatography (Figure 3A) and both
were detected by Western blot using homologous mouse
antiserum (Figure 3B). The yields of purified recombinant
proteins were approximately 0.6 mg/l for rSLP-1 and
approximately 0.1 mg/l for rSLP-1—pHW. The expression
yield of Sm-SLP-2 in pMelBac was only detectable by Western
blotting after extensive concentration of supernatant, and
was therefore considered too low to pursue (data not shown).
We did not attempt to express Sm-SLP-2 in the pHotWax
vector.
Recombinant SLP-1 is not hemolytic
Recombinant SLP-1 (containing the C-terminal purification
tags) was not functionally active in hemolysis assays (data not
shown), and dimer formation was not detected when the
recombinant protein was electrophoresed on native-polya-
crylamide gel electrophoresis (PAGE) gels under non-redu-
cing conditions (data not shown). Recombinant SLP-1—pHW
was not hemolytic and did not form dimers on native-PAGEFigure 3 Expression and purification of recombinant Sm-SLP-1
(rSLP-1) proteins in different expression vectors recombined
with baculovirus. (A) Coomassie Brilliant Blue-stained SDS-PAGE
gel of purified recombinant Sm-SLP-1 highlighting the size dif-
ference due to the different C-terminal purification tags. Lane 1,
rSLP-1; lane 2, rSLP-1—pHW. (B) Western blots showing recogni-
tion of recombinant proteins by homologous mouse antiserum.
Lanes 1 and 3, rSLP-1; lanes 2 and 4, rSLP-1—pHW. Lanes 1—2
probed with normal mouse serum; lanes 3—4 probed with mouse
anti-Sm-SLP-1. Molecular weight markers are shown in kDa on
the left.gels (data not shown). Extensive attempts to cleave the C-
terminal purification tags from rSLP-1—pHW using tobacco
etch virus (TEV) protease were unsuccessful, indicating that
the C-terminus might have been inaccessible to TEV protease
due to the fold of the recombinant proteins.19
Sm-SLP-1 is expressed in the gastrodermis of
adult worms and is recognized by sera from
infected mice
Antibodies to rSLP-1 were used to localize the native protein
to the gastrodermis of bothmale and female adult S. mansoni
by immunofluorescence (Figure 4). Pre-vaccination mouse
serum did not bind to any structures. Antiserum to rSLP-1 was
used to probe adult schistosome extracts solubilized in 1%
Triton X-100 in PBS (SmTX) electrophoresed under denaturing
and non-denaturing conditions (to address dimerization of
native SLPs), but bands were not detected by either method
(data not shown). The antiserum did, however, detect pro-
teins in immunohistochemistry, perhaps reflecting differen-
tial accessibility of epitopes when the proteins are
electrophoresed in a polyacrylamide gel compared with
parasite tissue sections. In addition, mouse antiserum to
rSLP-1 detected a protein in SmTX by ELISA, indicating that
antibodies to the recombinant product were able to detect
the native Sm-SLP-1 protein in a complex extract. Although
titers were low (1:800 from pooled serum — see next sec-
tion), Sm-SLP-1 would represent only a very minor compo-
nent of SmTX.
Sm-SLP-1 is a poor vaccine candidate in its
current form
Vaccination of CBA/CaH mice with rSLP-1 using a previously
established vaccination protocol that conferred protection
with other recombinant antigens22 did not result in a reduc-
tion in worm or egg burdens in vaccinated animals when
compared to controls (Table 1). Despite the presence of
antibody titers in excess of 1:100 000 against the recombi-
nant immunogen, adult worm and egg burdens recovered
from vaccinated mice were actually higher (but not statis-
tically significant) than those from control animals. More-
over, and as highlighted earlier, mouse antibodies to rSLP-1
recognized the native protein in the gastrodermis of adult
worms and in a complex parasite extract by ELISA. Sera from
vaccinated and control mice strongly recognized rSLP-1 after
parasite challenge (titers of 1:12 800 in control mice — Table
1), indicating that the protein is immunogenic during the
course of a natural murine infection with S. mansoni.
Recombinant Sm-SLP-1 is recognized by
antibodies from infected people
Recombinant SLP-1 was recognized by IgG from people living
in an area of high schistosomiasis transmission in the endemic
area of Melquiades, Brazil (Figure 5A). Stratification by WHO
class of infection25 showed that moderately (100—399 epg)
and heavily (399 epg ) infected individuals had significantly
higher levels of IgG than lightly infected (1—99 epg) and egg-
negative individuals from the same endemic area (p = 0.029).
The IgG levels to rSLP-1 between moderately and heavily
Figure 4 Immunostaining of adult mixed sex Schistosoma mansoni sections with mouse anti-Sm-SLP1 serum followed by anti-mouse-
Cy3 (red fluorescence) in all panels and DAPI (blue fluorescence to visualize nuclei) in panels A and B only. All images are shown with
corresponding bright field images on the left and fluorescent images on the right. Boxed regions are magnified on the far right of each
panel. (A) Section of a male worm probed with pre-immune serum (NMS). (B) Section of two male worms probed with anti-Sm-SLP-1
serum. (C) Section of paired male and female worms probed with anti-Sm-SLP-1 serum. Native Sm-SLP-1 was localized to the
gastrodermis (gas) of both male and female adult worms.
e44 T.A. Don et al.infected individuals did not differ significantly from each
other. Furthermore, residents of the endemic area who did
not have eggs in their feces — either putative resistant (PR)22
or egg-negative individuals — had higher IgG levels than
individuals who were not resident in the endemic area of
Melquiades (non-endemic controls) (p = 0.04 — not shown).
Egg-positive individuals had a significantly higher level of IgG
against rSLP-1 than PR individuals (p = 0.025) and individualsTable 1 Vaccination of mice with recombinant Sm-SLP-1 does not
Immunogen Absolute endpoint
titers to rSLP-1
Absolute endpoint
titers to SmTX
Pre-
challenge
Post-
challenge
Pre-
challenge
Post-
challenge
PBS + adjuvant ND 1:12 800 1:200 1:3200
rSLP-1 + adjuvant 1:102 400 1:51 200 1:800 1:3200
PBS, phosphate-buffered saline; ND, not determined.were egg-negative for other reasons (p = 0.025) from the
same endemic area (not shown). The increase and then
plateau of IgG levels of individuals with moderate to high
levels of infection suggests that a ‘threshold effect’ of IgG is
reached based upon the intensity of infection.
IgG responses to rSLP-1 showed similar distribution to
those against SmTX and SEA (schistosome egg antigen) (Fig-
ure 5B); IgG levels to both crude antigen extracts and rSLP-1protect against challenge infection with Schistosoma mansoni
No.
adult
worms
No.
female
worms
No.
male
worms
No.
eggs
in liver
Liver
weight
(g)
42  6 21  3 22  3 29 073  4199 2.448  0.131
57  4 28  2 29  2 48 560  2687 2.829  0.071
Figure 5 (A) The relationship between classes of infection
intensity of Schistosoma mansoni and mean IgG against recom-
binant Sm-SLP-1. Bars represent standard error of the mean;
epg, eggs per gram of feces. Classes of infection intensity are set
forth by Montresor et al.25 PR = putative resistant (see reference
22). (B) The relationship between infection status of endemic-
negative, endemic-positive, and PR individuals and IgG reactivity
to recombinant Sm-SLP-1 and crude schistosome adult worm
(SmTX) and egg (SEA) antigens. The endemic-positive group
was generated from a pool of the three groups of infected people
(light, moderate, and heavy) shown in panel A. Bars represent
standard errors of the mean.
Saposin-like proteins in Schistosoma mansoni e45were elevated in egg-positive individuals. Though statisti-
cally significant (p = 0.01), only moderate correlations of
0.383 for SmTX and rSLP-1 and 0.334 for SEA and rSLP-1 were
found, indicating that while IgG levels were elevated against
these three antigens in infected individuals, absolute levels
of IgG to each differed. The correlation of IgG levels between
SmTX and SEA in infected individuals was 0.845 (p = 0.01).
Sera from patients resident in Melquiades whoweremono-
infected with hookworm (n = 5), Ascaris (n = 5), Leishmania
(n = 5), and Toxoplasma, all prevalent in this region of Brazil,
did not have detectable antibody responses to rSLP-1 (not
shown).
Discussion
Here we describe the cloning and expression of two S.
mansoni cDNAs encoding SAPLIPs, localization of one of
the proteins (SLP-1) to the gastrodermis of adult worms,
and serologic recognition of SLP-1 by infected humans and
animals. Sm-SLP-1 and SLP-2 conform to the characteristics
of the SAPLIP family, specifically the presence of six cysteine
residues (which are predicted to form three disulfide bonds)
and the distribution of conserved hydrophobic residues.16
The disulfide bonds and predicted structure, which is based
on amoebapore A,26 confers remarkable stability to theproteins.10,13,27 Due to the low sequence homology between
SAPLIPs other than those shared residues described above, it
is difficult to hypothesize specific functions on sequence
alone, but as SAPLIPs in general interact with lipids on cell
membranes,13,16 these schistosome SAPLIPs in the gastroder-
mis might well interact with lipids on the surface of ingested
host cells.
Dimerization is a common feature of many SAPLIPs, but
occurs via differentmechanisms in different proteins.16 Some
SAPLIPs dimerize via an intermolecular disulfide bond, while
others rely on electrostatic interactions. Amoebapore A uses
a head-to-tail mechanism via a C-terminal histidine.24
Although some helminth SAPLIPs do possess C-terminal his-
tidines that are potentially involved in dimerization,10,19
neither Sm-SLP-1 nor either SAPLIP domain of Sm-SLP-2 have
an equivalent C-terminal histidine. However, a single S.
mansoni ESTencoding a SAPLIP domain (Q26536) did contain
a C-terminal histidine (Figure 1), suggesting that this protein
might form dimers in a similar manner to amoebapore A.
Human saposin isoforms (A—D) share little sequence identity
other than a strictly conserved tyrosine and proline, and the
tyrosine located in the loop between helices 3 and 4
(between the fourth and fifth cysteines) was also conserved
in Sm-SLP-1 and SLP-2, suggesting that these two proteins
(and other predicted S. mansoni proteins — Figure 1) are
more similar to saposins than to other sub-families of
SAPLIPs.
No hemolytic activity was identified in rSLP-1, but this
may be due to the presence of the purification tags at the
C-terminus, which could be interfering with potential dimer-
ization or proper folding of the recombinant protein. Simi-
larly, clonorin from C. sinensis was only able to lyse
erythrocytes after removal of its C-terminal purification
tag,10 so we expressed rSLP-1—pHW with a potentially clea-
vable C-terminus. Even after numerous attempts, no clea-
vage was seen at the TEV site, possibly due to the inability of
the protease to interact with the cleavage site due to steric
occlusion by ordered structures in the recombinant protein
(http://mcl1.ncifcrf.gov/waugh_tech/faq/tev.pdf). To
combat this problem, addition of extra residues between
the cleavage site and recombinant protein may allow TEV to
cleave more efficiently. However, this would have defeated
the purpose of expressing rSLP-1 with a cleavable tag to allow
potential head-to-tail dimerization.
Sm-SLP-1 is expressed in the gastrodermis of adult schis-
tosomes and could therefore be involved in lysis of ingested
red cells, similar to the predicted role of C. sinensis clo-
norin10 and Fasciola gigantica SAPLIPs,28 which are also
localized in the gastrodermis. However, production of active
recombinant Sm-SLP-1 and SLP-2, or silencing of the respec-
tive mRNAs is needed to better understand their biological
functions and confirm a role in hemolysis. Other potential
roles of a gastrodermal SAPLIP might include acquisition and
transport across the gastrodermal cells of host lipids from
serum as a source of nutrition.29
Rabbits vaccinated with rFhSAP2 are protected against F.
hepatica challenge infection,30 suggesting that SAPLIPs are
efficacious vaccine antigens against trematode parasites.
Even though rSLP-1 is immunogenic in natural infections
and upon immunization with recombinant, adjuvant protein,
it offers no protection against parasite challenge under the
conditions assessed here. One cannot completely discount
e46 T.A. Don et al.the potential of this protein as a vaccine. Its poor efficacy in
this study might reflect incorrect folding/multimerization,
thus not presenting epitopes that might be protective. More-
over, the mRNA for Sm-slp-1is expressed in larval schisto-
somes as well as adult worms,23 suggesting that it is also
accessible as a target during the early stages of infection in
the mammalian host.
Sm-SLP-1 was not recognized by individuals who resided
outside an area of active S. mansoni transmission. However,
rSLP-1 was recognized by all three categories of individuals
resident in an area of active S. mansoni transmission:22 (1)
putative resistant (PR), (2) egg-negative, and (3) egg-posi-
tive individuals. There were statistically significant differ-
ences in the IgG levels to rSLP-1 among these groups from the
endemic area, with putative resistant and egg-negative
individuals having significantly lower levels of IgG to rSLP-
1 than individuals whowere egg-positive. The lower levels of
IgG in the egg-negative group (but higher than that of the
non-endemic controls) could be attributed to several fac-
tors, including previous infection, which resolved by
changes in water contact behavior, or by treatment with
praziquantel. The lower levels of IgG in putative resistants
might reflect a lack of exposure to SLP-1, because these
individuals are usually egg-negative and their immune
response is thought to kill the parasite before it reaches
maturity and consumes large amounts of blood. Schisto-
somes have a blind gut and regurgitate as they feed, provid-
ing a likely mechanism by which a protein in the
gastrodermis, such as SLP-1, is released into the blood
stream. Sm-slp-1 mRNA is expressed in cercariae as well
as adult worms,23 suggesting that the juvenile parasites
might also release SLP-1 into the host environment.
Individuals with an active infection (egg-positive) had
significantly higher levels of IgG to rSLP-1 than did egg-
negative individuals. Further analyses, stratified by infection
intensity as defined by theWHO, showed that individuals with
moderate or heavy infection had a significantly higher level
of IgG against rSLP-1 in contrast to individuals with a lower
level of infection intensity, regardless of age and sex (data
not shown). The increase and then plateau of anti-SLP-1 IgG
among individuals with moderate to high levels of schisto-
some infection suggests a ‘threshold effect’ in which a
certain level of IgG is reached based upon the intensity of
infection. Future work should address the relationship
between antibody levels to SLP-1 and schistosomiasis infec-
tion intensity, including further characterization of the
humoral (isotype and IgG subclass) and cellular responses
to this antigen.
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